Evaluation of Indocyanine Green-guided Systematic Pelvic Lymphadenectomy in Endometrial and Cervical Cancer
Study Details
Study Description
Brief Summary
The lymph nodes involvement is one of the most important prognostic factors in endometrial (EC) and cervical cancer (CC). Indeed, the lymph node involvement in cancer patients modifies the International Federation of Gynecology and Obstetrics (FIGO) stage and plays a pivotal role in the choice of the adjuvant therapy.
Since the modern imaging techniques are not yet able to accurately detect lymph nodes metastasis, pelvic systematic lymphadenectomy has still an important role and it still represents the gold standard in EC and CC. The sentinel lymph node (SLN) biopsy, which is a standard practice in breast cancer and melanoma, is often used in some early stage gynaecological cancers such as EC and CC.
Indocyanine green (ICG) is the most used tracer for the detection of SLN in gynaecological cancer, especially in laparoendoscopic setting. ICG allows a complete visualization of the lymphatic drainage and, for this reason, it may be used even in systematic pelvic lymphadenectomy to guide the surgeon during the procedure. Several studies have demonstrated an advantage of the ICG-guided lymphadenectomy in other types of cancers, showing a higher number of lymph nodes removed with this technique when compared to standard lymphadenectomy (without ICG).
To date, there is no published study about ICG-guided systematic pelvic lymphadenectomy in EC and CC. In this scenario, the aim of this study will be to compare systematic ICG-guided pelvic lymphadenectomy and standard lymphadenectomy in EC and CC.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Indocyanine green Women with endometrial and cervical cancer undergoing indocyanine green-guided systematic pelvic lymphadenectomy by laparoscopy or robotic surgery |
Procedure: Indocyanine green-guided systematic pelvic lymphadenectomy
Injection of Indocyanine green within the uterine cervix before to perform laparoscopic/robotic systematic pelvic lymphadenectomy
|
| Control Women with endometrial and cervical cancer undergoing systematic pelvic lymphadenectomy by laparoscopy or robotic surgery without the use of indocyanine green tracer injection. |
Outcome Measures
Primary Outcome Measures
- Retrieved lymph nodes [At the moment of the surgery]
Number of retrieved lymph nodes after laparoscopic/robotic systematic pelvic lymphadenectomy
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Women affected by endometrial or cervical cancer
-
Laparoscopic/robotic surgical approach with systematic pelvic lymphadenectomy.
Exclusion Criteria:
- Women undergoing open surgery (laparotomy) for the surgical management of endometrial or cervical cancer.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Università degli Studi dell'Insubria
Investigators
- Principal Investigator: Benito Chiofalo, M.D., Regina Elena National Cancer Institute, Rome, Italy
- Study Chair: Antonio Simone Laganà, M.D., Ph.D., Università degli Studi dell'Insubria
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- GREEN-1